Fresenius Medical Care AG (FME)
Industry Medical Care Facilities
This stock can be held in an Investment ISA and an Investment Account
Sell
€40.06
Buy
€40.14
€0.00 (+0.00%)
Prices updated at 12 Dec 2025, 19:30 CET
| Prices minimum 15 mins delay
Prices in EUR
Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. It develops and manufactures a full range of dialysis machines, systems, and disposable products. The company provides dialysis care and related services.
-0.53%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 19,454m | 19,336m | |
| 4,925m | 4,757m | |
| 1,477m | 1,467m | |
| 7.59 | 7.59 | |
| 499m | 538m | |
| 3,210m | 3,206m | |
| Sales, General and administrative | 3,196m | 3,143m |
| Interest expenses | 425m | 407m |
| Provision for income taxes | 301m | 316m |
| Operating expenses | 3,448m | 3,289m |
| Income before taxes | 1,033m | 1,057m |
| Net income available to common shareholders | 499m | 538m |
| 1.7 | 1.83 | |
| Net interest income | -336m | -335m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 1.7 | 1.83 |
| Free cash flow per share | 6.2904 | 5.2527 |
| Book value/share | 47.7366 | 46.2989 |
| Debt equity ratio | 0.770092 | 0.669612 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 8,701m | 7,923m |
| Current liabilities | 6,112m | 5,660m |
| Total capital | 20,580m | 20,837m |
| Total debt | 12,050m | 10,979m |
| Total equity | 13,620m | 14,577m |
| Total non current liabilities | - | - |
| Loans | 6,960m | 6,261m |
| Total assets | 33,930m | 33,567m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1,403m | 1,151m |
| Common stock | 293m | 293m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 1,274m | 1,427m |
| Cash dividends paid | -329m | -349m |
| 1,944m | 1,687m | |
| Investments (gains) losses | -544m | -85m |
| 1,427m | 1,185m | |
| Net income | - | - |
| 2,629m | 2,386m | |
| -685m | -699m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
